Literature DB >> 29891724

The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.

Peter Barry1, Alexandra Vatsiou2, Inmaculada Spiteri2, Daniel Nichol2, George D Cresswell2, Ahmet Acar2, Nicholas Trahearn2, Sarah Hrebien3, Isaac Garcia-Murillas3, Kate Chkhaidze2, Luca Ermini4, Ian Said Huntingford5, Hannah Cottom3, Lila Zabaglo6, Konrad Koelble6, Saira Khalique6, Jennifer E Rusby1, Francesca Muscara1, Mitch Dowsett6, Carlo C Maley2,7, Rachael Natrajan3, Yinyin Yuan4, Gaia Schiavon3, Nicholas Turner3, Andrea Sottoriva8.   

Abstract

Purpose: The most significant prognostic factor in early breast cancer is lymph node involvement. This stage between localized and systemic disease is key to understanding breast cancer progression; however, our knowledge of the evolution of lymph node malignant invasion remains limited, as most currently available data are derived from primary tumors.Experimental Design: In 11 patients with treatment-naïve node-positive early breast cancer without clinical evidence of distant metastasis, we investigated lymph node evolution using spatial multiregion sequencing (n = 78 samples) of primary and lymph node deposits and genomic profiling of matched longitudinal circulating tumor DNA (ctDNA).
Results: Linear evolution from primary to lymph node was rare (1/11), whereas the majority of cases displayed either early divergence between primary and nodes (4/11) or no detectable divergence (6/11), where both primary and nodal cells belonged to a single recent expansion of a metastatic clone. Divergence of metastatic subclones was driven in part by APOBEC. Longitudinal ctDNA samples from 2 of 7 subjects with evaluable plasma taken perioperatively reflected the two major evolutionary patterns and demonstrate that private mutations can be detected even from early metastatic nodal deposits. Moreover, node removal resulted in disappearance of private lymph node mutations in ctDNA.Conclusions: This study sheds new light on a crucial evolutionary step in the natural history of breast cancer, demonstrating early establishment of axillary lymph node metastasis in a substantial proportion of patients. Clin Cancer Res; 24(19); 4763-70. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891724      PMCID: PMC6296441          DOI: 10.1158/1078-0432.CCR-17-3374

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  25 in total

1.  A population-based validation of the prognostic model PREDICT for early breast cancer.

Authors:  G C Wishart; C D Bajdik; E M Azzato; E Dicks; D C Greenberg; J Rashbass; C Caldas; P D P Pharoah
Journal:  Eur J Surg Oncol       Date:  2011-03-02       Impact factor: 4.424

2.  Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.

Authors:  Charlotte K Y Ng; Francois-Clement Bidard; Salvatore Piscuoglio; Felipe C Geyer; Raymond S Lim; Ino de Bruijn; Ronglai Shen; Fresia Pareja; Samuel H Berman; Lu Wang; Jean-Yves Pierga; Anne Vincent-Salomon; Agnes Viale; Larry Norton; Brigitte Sigal; Britta Weigelt; Paul Cottu; Jorge S Reis-Filho
Journal:  Clin Cancer Res       Date:  2017-03-28       Impact factor: 12.531

3.  Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

Authors:  Peter Eirew; Adi Steif; Jaswinder Khattra; Gavin Ha; Damian Yap; Hossein Farahani; Karen Gelmon; Stephen Chia; Colin Mar; Adrian Wan; Emma Laks; Justina Biele; Karey Shumansky; Jamie Rosner; Andrew McPherson; Cydney Nielsen; Andrew J L Roth; Calvin Lefebvre; Ali Bashashati; Camila de Souza; Celia Siu; Radhouane Aniba; Jazmine Brimhall; Arusha Oloumi; Tomo Osako; Alejandra Bruna; Jose L Sandoval; Teresa Algara; Wendy Greenwood; Kaston Leung; Hongwei Cheng; Hui Xue; Yuzhuo Wang; Dong Lin; Andrew J Mungall; Richard Moore; Yongjun Zhao; Julie Lorette; Long Nguyen; David Huntsman; Connie J Eaves; Carl Hansen; Marco A Marra; Carlos Caldas; Sohrab P Shah; Samuel Aparicio
Journal:  Nature       Date:  2014-11-26       Impact factor: 49.962

4.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers.

Authors:  Sohrab P Shah; Andrew Roth; Rodrigo Goya; Arusha Oloumi; Gavin Ha; Yongjun Zhao; Gulisa Turashvili; Jiarui Ding; Kane Tse; Gholamreza Haffari; Ali Bashashati; Leah M Prentice; Jaswinder Khattra; Angela Burleigh; Damian Yap; Virginie Bernard; Andrew McPherson; Karey Shumansky; Anamaria Crisan; Ryan Giuliany; Alireza Heravi-Moussavi; Jamie Rosner; Daniel Lai; Inanc Birol; Richard Varhol; Angela Tam; Noreen Dhalla; Thomas Zeng; Kevin Ma; Simon K Chan; Malachi Griffith; Annie Moradian; S-W Grace Cheng; Gregg B Morin; Peter Watson; Karen Gelmon; Stephen Chia; Suet-Feung Chin; Christina Curtis; Oscar M Rueda; Paul D Pharoah; Sambasivarao Damaraju; John Mackey; Kelly Hoon; Timothy Harkins; Vasisht Tadigotla; Mahvash Sigaroudinia; Philippe Gascard; Thea Tlsty; Joseph F Costello; Irmtraud M Meyer; Connie J Eaves; Wyeth W Wasserman; Steven Jones; David Huntsman; Martin Hirst; Carlos Caldas; Marco A Marra; Samuel Aparicio
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

Review 5.  Inferring the Origin of Metastases from Cancer Phylogenies.

Authors:  Woo Suk Hong; Max Shpak; Jeffrey P Townsend
Journal:  Cancer Res       Date:  2015-08-10       Impact factor: 12.701

6.  Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.

Authors:  David Olmeda; Daniela Cerezo-Wallis; Erica Riveiro-Falkenbach; Paula C Pennacchi; Marta Contreras-Alcalde; Nuria Ibarz; Metehan Cifdaloz; Xavier Catena; Tonantzin G Calvo; Estela Cañón; Direna Alonso-Curbelo; Javier Suarez; Lisa Osterloh; Osvaldo Graña; Francisca Mulero; Diego Megías; Marta Cañamero; Jorge L Martínez-Torrecuadrada; Chandrani Mondal; Julie Di Martino; David Lora; Inés Martinez-Corral; J Javier Bravo-Cordero; Javier Muñoz; Susana Puig; Pablo Ortiz-Romero; José L Rodriguez-Peralto; Sagrario Ortega; María S Soengas
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

7.  Multiregional Tumor Trees Are Not Phylogenies.

Authors:  João M Alves; Tamara Prieto; David Posada
Journal:  Trends Cancer       Date:  2017-07-17

8.  Mutational processes molding the genomes of 21 breast cancers.

Authors:  Serena Nik-Zainal; Ludmil B Alexandrov; David C Wedge; Peter Van Loo; Christopher D Greenman; Keiran Raine; David Jones; Jonathan Hinton; John Marshall; Lucy A Stebbings; Andrew Menzies; Sancha Martin; Kenric Leung; Lina Chen; Catherine Leroy; Manasa Ramakrishna; Richard Rance; King Wai Lau; Laura J Mudie; Ignacio Varela; David J McBride; Graham R Bignell; Susanna L Cooke; Adam Shlien; John Gamble; Ian Whitmore; Mark Maddison; Patrick S Tarpey; Helen R Davies; Elli Papaemmanuil; Philip J Stephens; Stuart McLaren; Adam P Butler; Jon W Teague; Göran Jönsson; Judy E Garber; Daniel Silver; Penelope Miron; Aquila Fatima; Sandrine Boyault; Anita Langerød; Andrew Tutt; John W M Martens; Samuel A J R Aparicio; Åke Borg; Anne Vincent Salomon; Gilles Thomas; Anne-Lise Børresen-Dale; Andrea L Richardson; Michael S Neuberger; P Andrew Futreal; Peter J Campbell; Michael R Stratton
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

9.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

Authors:  P McGale; C Taylor; C Correa; D Cutter; F Duane; M Ewertz; R Gray; G Mannu; R Peto; T Whelan; Y Wang; Z Wang; S Darby
Journal:  Lancet       Date:  2014-03-19       Impact factor: 79.321

10.  Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Authors:  Serena Nik-Zainal; Helen Davies; Johan Staaf; Manasa Ramakrishna; Dominik Glodzik; Xueqing Zou; Inigo Martincorena; Ludmil B Alexandrov; Sancha Martin; David C Wedge; Peter Van Loo; Young Seok Ju; Marcel Smid; Arie B Brinkman; Sandro Morganella; Miriam R Aure; Ole Christian Lingjærde; Anita Langerød; Markus Ringnér; Sung-Min Ahn; Sandrine Boyault; Jane E Brock; Annegien Broeks; Adam Butler; Christine Desmedt; Luc Dirix; Serge Dronov; Aquila Fatima; John A Foekens; Moritz Gerstung; Gerrit K J Hooijer; Se Jin Jang; David R Jones; Hyung-Yong Kim; Tari A King; Savitri Krishnamurthy; Hee Jin Lee; Jeong-Yeon Lee; Yilong Li; Stuart McLaren; Andrew Menzies; Ville Mustonen; Sarah O'Meara; Iris Pauporté; Xavier Pivot; Colin A Purdie; Keiran Raine; Kamna Ramakrishnan; F Germán Rodríguez-González; Gilles Romieu; Anieta M Sieuwerts; Peter T Simpson; Rebecca Shepherd; Lucy Stebbings; Olafur A Stefansson; Jon Teague; Stefania Tommasi; Isabelle Treilleux; Gert G Van den Eynden; Peter Vermeulen; Anne Vincent-Salomon; Lucy Yates; Carlos Caldas; Laura van't Veer; Andrew Tutt; Stian Knappskog; Benita Kiat Tee Tan; Jos Jonkers; Åke Borg; Naoto T Ueno; Christos Sotiriou; Alain Viari; P Andrew Futreal; Peter J Campbell; Paul N Span; Steven Van Laere; Sunil R Lakhani; Jorunn E Eyfjord; Alastair M Thompson; Ewan Birney; Hendrik G Stunnenberg; Marc J van de Vijver; John W M Martens; Anne-Lise Børresen-Dale; Andrea L Richardson; Gu Kong; Gilles Thomas; Michael R Stratton
Journal:  Nature       Date:  2016-05-02       Impact factor: 49.962

View more
  13 in total

1.  A phylogenetic approach to study the evolution of somatic mutational processes in cancer.

Authors:  Sayaka Miura; Tracy Vu; Jiyeong Choi; Jeffrey P Townsend; Sajjad Karim; Sudhir Kumar
Journal:  Commun Biol       Date:  2022-06-22

Review 2.  Tracking Cancer Evolution through the Disease Course.

Authors:  Chris Bailey; James R M Black; James L Reading; Kevin Litchfield; Samra Turajlic; Nicholas McGranahan; Mariam Jamal-Hanjani; Charles Swanton
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

3.  Effect of neoadjuvant therapy on breast cancer biomarker profile.

Authors:  Laura Rey-Vargas; Juan Carlos Mejía-Henao; María Carolina Sanabria-Salas; Silvia J Serrano-Gomez
Journal:  BMC Cancer       Date:  2020-07-18       Impact factor: 4.430

4.  Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

Authors:  Jennifer L Caswell-Jin; Katherine McNamara; Johannes G Reiter; Ruping Sun; Zheng Hu; Zhicheng Ma; Jie Ding; Carlos J Suarez; Susanne Tilk; Akshara Raghavendra; Victoria Forte; Suet-Feung Chin; Helen Bardwell; Elena Provenzano; Carlos Caldas; Julie Lang; Robert West; Debu Tripathy; Michael F Press; Christina Curtis
Journal:  Nat Commun       Date:  2019-02-08       Impact factor: 14.919

5.  Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer.

Authors:  Xiang Cui; Hao Zhu; Jisheng Huang
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

Review 6.  The role of single-cell sequencing in studying tumour evolution.

Authors:  Maximilian Mossner; Ann-Marie C Baker; Trevor A Graham
Journal:  Fac Rev       Date:  2021-05-26

7.  Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.

Authors:  Dimitrios Kleftogiannis; Marco Punta; Anuradha Jayaram; Shahneen Sandhu; Stephen Q Wong; Delila Gasi Tandefelt; Vincenza Conteduca; Daniel Wetterskog; Gerhardt Attard; Stefano Lise
Journal:  BMC Med Genomics       Date:  2019-08-02       Impact factor: 3.063

8.  Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking.

Authors:  George D Cresswell; Daniel Nichol; Inmaculada Spiteri; Haider Tari; Luis Zapata; Timon Heide; Carlo C Maley; Luca Magnani; Gaia Schiavon; Alan Ashworth; Peter Barry; Andrea Sottoriva
Journal:  Nat Commun       Date:  2020-03-27       Impact factor: 14.919

9.  Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital.

Authors:  Peeter Karihtala; Anniina Jääskeläinen; Nelli Roininen; Arja Jukkola
Journal:  BMJ Open       Date:  2020-10-12       Impact factor: 2.692

10.  EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer.

Authors:  Kousho Wakae; Satoru Kondo; Hai Thanh Pham; Naohiro Wakisaka; Lusheng Que; Yingfang Li; Xin Zheng; Kento Fukano; Kouichi Kitamura; Koichi Watashi; Hideki Aizaki; Takayoshi Ueno; Makiko Moriyama-Kita; Kazuya Ishikawa; Yosuke Nakanishi; Kazuhira Endo; Masamichi Muramatsu; Tomokazu Yoshizaki
Journal:  Cancer Med       Date:  2020-08-20       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.